Immune Pharmaceuticals Inc. is focused on developing the next generation of monoclonal antibodies to address significant unmet medical needs in the treatment of cancer and inflammatory diseases. Our goal is to improve patients lives through targeted medicine.
Quote | Immune Pharmaceuticals Inc. (OTCMKTS:IMNP)
Last: | $ |
---|---|
Change Percent: | -39.62% |
Open: | $0.0045 |
Close: | $0.0032 |
High: | $0.0051 |
Low: | $0.0023 |
Volume: | 29,099,001 |
Last Trade Date Time: | 12/31/1969 07:00:00 pm |
News | Immune Pharmaceuticals Inc. (OTCMKTS:IMNP)
FORT LEE, N.J., Feb. 19, 2019 (GLOBE NEWSWIRE) -- Immune Pharmaceuticals, Inc. (OTCQB: IMNP) (“Immune” or the “Company”), a biopharmaceutical company developing novel therapeutic agents for the treatment of immunologic and inflammatory diseases, has filed for...
Message Board Posts | Immune Pharmaceuticals Inc. (OTCMKTS:IMNP)
Subject | By | Source | When |
---|---|---|---|
There are two Immunes. There is one in | Letterpenny | investorshub | 09/04/2022 2:51:10 PM |
There is already a board here for IMNP: | Koog | investorshub | 09/04/2022 2:40:58 PM |
Hi Board. Hope all is well. Just wanted | Letterpenny | investorshub | 09/04/2022 2:37:43 PM |
News, Short Squeeze, Breakout and More Instantly...
Immune Pharmaceuticals Inc. Company Name:
IMNP Stock Symbol:
OTCMKTS Market:
Immune Pharmaceuticals Inc. Website:
FORT LEE, N.J., Feb. 19, 2019 (GLOBE NEWSWIRE) -- Immune Pharmaceuticals, Inc. (OTCQB: IMNP) (“Immune” or the “Company”), a biopharmaceutical company developing novel therapeutic agents for the treatment of immunologic and inflammatory diseases, has filed for...